Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Antiseptic Gargles on Oral Microbiome
NCT03141554Phase 4Completed
- Sponsor
- Mundipharma
- Start
- May 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of povidone-iodine 1% mouthwash and gargle in Oral infections (3 arms), sponsored by Mundipharma. Primary endpoints: Composition of oral microbiome - reduction of microflora and Composition of oral microbiome - maintenance of healthy microflora. Started May 2017; status: completed.
02
Drugs
povidone-iodine 1% mouthwash and gargle
03
Conditions
Oral infections
Beyond the preview
Go deeper on NCT03141554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03141554.